Resultados da pesquisa - Morgan Macbeth

A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine Por Chiara R. Dart, Nabanita Mukherjee, Carol M. Amato, Anabel Goulding, Morgan MacBeth, Robert Van Gulick, Kasey L. Couts, James R. Lambert, David A. Norris, William A. Robinson, Yiqun G. Shellman

Obter o texto integral

Targeting liver metastases in uveal melanoma: ATX-LPA mediated immunosuppression and novel therapeutic approaches Por Jacqueline A. Turner, Jacqueline A. Turner, Marc D’Antonio, Heather N. Montane, Morgan MacBeth, Elizabeth Katsnelson, William A. Robinson, Richard P. Tobin, Kasey L. Couts, Svetomir N. Markovic, Raul M. Torres

Obter o texto integral

Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis Por Stephen G. Smoots, Anna R. Schreiber, Marilyn M. Jackson, Stacey M. Bagby, Adrian T A. Dominguez, Evan D. Dus, Cameron A. Binns, Morgan MacBeth, Phaedra A. Whitty, Jennifer R. Diamond, Todd M. Pitts

Obter o texto integral

Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer model Por Robert W. Lentz, Adrian T. A. Dominguez, Nicole Baranda Balmaceda, John J. Arcaroli, Stacey M. Bagby, Cameron A. Binns, Stephen G. Smoots, Marilyn M. Jackson, Morgan Macbeth, Tessa Holmstoen, Tapahsama Banerjee, Phaedra A. Whitty, S. Stephen Yi, Christopher H. Lieu, Wells A. Messersmith, Todd M. Pitts

Obter o texto integral